These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36307657)

  • 21. Pre-operative cognitive burden as predictor of motor outcome following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Tang V; Zhu XL; Lau C; Chan A; Ma K; Yeung J; Cheung T; Abrigo J; Chan DYC; Chan D; Mok V; Poon WS
    Neurol Sci; 2022 Dec; 43(12):6803-6811. PubMed ID: 36048377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and Chronic Mood and Apathy Outcomes from a randomized study of unilateral STN and GPi DBS.
    Okun MS; Wu SS; Fayad S; Ward H; Bowers D; Rosado C; Bowen L; Jacobson C; Butson C; Foote KD
    PLoS One; 2014; 9(12):e114140. PubMed ID: 25469706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
    Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
    J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation.
    Yamamoto T; Yamanaka Y; Hirano S; Higuchi Y; Kuwabara S
    Front Neurol; 2022; 13():1042033. PubMed ID: 36686507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Chou KL; Persad CC; Patil PG
    Parkinsonism Relat Disord; 2012 Jun; 18(5):510-3. PubMed ID: 22341622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease.
    Chou KL; Taylor JL; Patil PG
    Parkinsonism Relat Disord; 2013 Nov; 19(11):966-9. PubMed ID: 23849499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
    Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
    Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. King's Parkinson's Disease Pain Scale for Assessment of Pain Relief Following Deep Brain Stimulation for Parkinson's Disease.
    DiMarzio M; Pilitsis JG; Gee L; Peng S; Prusik J; Durphy J; Ramirez-Zamora A; Hanspal E; Molho E; McCallum SE
    Neuromodulation; 2018 Aug; 21(6):617-622. PubMed ID: 29608802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Higuchi MA; Tsuboi Y; Inoue T; Fukuyama K; Abe H; Baba Y; Yamada T
    Neuromodulation; 2015 Feb; 18(2):113-7. PubMed ID: 24799286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential neuromodulatory impact of subthalamic nucleus deep brain stimulation on Parkinson's disease progression.
    Szlufik S; Duszynska-Lysak K; Przybyszewski A; Laskowska-Levy I; Drzewinska A; Dutkiewicz J; Mandat T; Habela P; Koziorowski D
    J Clin Neurosci; 2020 Mar; 73():150-154. PubMed ID: 32001113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.
    Hanna JA; Scullen T; Kahn L; Mathkour M; Gouveia EE; Garces J; Evans LM; Lea G; Houghton DJ; Biro E; Bui CJ; Sulaiman OA; Smith RD
    J Neurosurg; 2019 Sep; 131(3):807-812. PubMed ID: 30265192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    Bargiotas P; Eugster L; Oberholzer M; Debove I; Lachenmayer ML; Mathis J; Pollo C; Schüpbach WMM; Bassetti CL
    PLoS One; 2017; 12(12):e0190027. PubMed ID: 29253029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.
    Fabbri M; Coelho M; Guedes LC; Rosa MM; Abreu D; Gonçalves N; Antonini A; Ferreira JJ
    Parkinsonism Relat Disord; 2017 Aug; 41():113-117. PubMed ID: 28528805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease.
    Li H; Liang S; Yu Y; Wang Y; Cheng Y; Yang H; Tong X
    PLoS One; 2020; 15(9):e0238936. PubMed ID: 32915893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A Clinical Study of Patients with Primary Parkinson's Disease Undergoing Bilateral Deep Brain Stimulation (STN-DBS) Surgery in the Subthalamic Nucleus under General Anesthesia].
    Shi YF; Zhang Y; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):583-587. PubMed ID: 35871727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination targeting of subthalamic nucleus and ventral intermediate thalamic nucleus with a single trajectory in deep brain stimulation for tremor-dominant Parkinson's disease.
    Fayed I; Cobourn KD; Pivazyan G; Torres-Yaghi YA; Pagan FL; Lo SE; Mandir AS; Kalhorn CG
    J Clin Neurosci; 2021 Mar; 85():92-100. PubMed ID: 33581797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.